clinical trial · NCT07766369
A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants
Healthy VolunteersE2086
brief summary
The primary purpose of this study is to assess potential drug-drug interactions of E2086 when coadministered orally with Itraconazole, Carbamazepine, Midazolam, Dextromethorphan, Bupropion, or Combined Oral Contraceptives in Healthy Participants
started
Aug 12, 2026
primary completion
Nov 12, 2026
completion
Nov 12, 2026
last updated
Aug 14, 2026
official title
A Phase 1, Open-label, 3-Part Study to Assess Potential Drug-Drug Interactions of E2086 When Coadministered Orally With Itraconazole, Carbamazepine, Midazolam, Dextromethorphan, Bupropion, or Combined Oral Contraceptives in Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol